- Home
- SQFT vs IBO Comparison
SQFT vs IBO Comparison
Compare SQFT & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- IBO
- Stock Information
- Founded
- SQFT 1999
- IBO 2018
- Country
- SQFT United States
- IBO United States
- Employees
- SQFT N/A
- IBO N/A
- Industry
- SQFT Real Estate Investment Trusts
- IBO
- Sector
- SQFT Real Estate
- IBO
- Exchange
- SQFT Nasdaq
- IBO NYSE
- Market Cap
- SQFT 6.2M
- IBO 5.8M
- IPO Year
- SQFT 2020
- IBO 2024
- Fundamental
- Price
- SQFT $5.15
- IBO $0.58
- Analyst Decision
- SQFT
- IBO
- Analyst Count
- SQFT 0
- IBO 0
- Target Price
- SQFT N/A
- IBO N/A
- AVG Volume (30 Days)
- SQFT 12.4K
- IBO 23.4M
- Earning Date
- SQFT 08-13-2025
- IBO 08-23-2025
- Dividend Yield
- SQFT N/A
- IBO N/A
- EPS Growth
- SQFT N/A
- IBO N/A
- EPS
- SQFT N/A
- IBO N/A
- Revenue
- SQFT $18,260,398.00
- IBO N/A
- Revenue This Year
- SQFT $23.63
- IBO N/A
- Revenue Next Year
- SQFT N/A
- IBO N/A
- P/E Ratio
- SQFT N/A
- IBO N/A
- Revenue Growth
- SQFT N/A
- IBO N/A
- 52 Week Low
- SQFT $4.19
- IBO $0.36
- 52 Week High
- SQFT $8.77
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- SQFT 51.05
- IBO N/A
- Support Level
- SQFT $4.55
- IBO N/A
- Resistance Level
- SQFT $5.77
- IBO N/A
- Average True Range (ATR)
- SQFT 0.37
- IBO 0.00
- MACD
- SQFT 0.09
- IBO 0.00
- Stochastic Oscillator
- SQFT 56.96
- IBO 0.00
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.